|
ASX - By Stock
|
RAC |
Re:
Chat GPT Q&A
|
|
RaceOncology
|
641 |
233K |
62 |
14/12/25 |
| 14/12/25 |
ASX - By Stock
|
641
|
233K
|
62
|
|
|
ASX - By Stock
|
RAC |
Re:
Chat GPT Q&A
|
|
RaceOncology
|
641 |
233K |
45 |
14/12/25 |
| 14/12/25 |
ASX - By Stock
|
641
|
233K
|
45
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Discovery of the Anticancer Mechanism of (EE)-bisantrene
|
|
RaceOncology
|
370 |
97K |
27 |
14/12/25 |
| 14/12/25 |
ASX - By Stock
|
370
|
97K
|
27
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Breakthrough Composition of Matter IP Discovery
|
|
RaceOncology
|
377 |
102K |
7 |
14/12/25 |
| 14/12/25 |
ASX - By Stock
|
377
|
102K
|
7
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Breakthrough Composition of Matter IP Discovery
|
|
RaceOncology
|
377 |
102K |
36 |
12/12/25 |
| 12/12/25 |
ASX - By Stock
|
377
|
102K
|
36
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Breakthrough Composition of Matter IP Discovery
|
|
RaceOncology
|
377 |
102K |
51 |
12/12/25 |
| 12/12/25 |
ASX - By Stock
|
377
|
102K
|
51
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Breakthrough Composition of Matter IP Discovery
|
|
RaceOncology
|
377 |
102K |
38 |
12/12/25 |
| 12/12/25 |
ASX - By Stock
|
377
|
102K
|
38
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Breakthrough Composition of Matter IP Discovery
|
|
RaceOncology
|
377 |
102K |
37 |
12/12/25 |
| 12/12/25 |
ASX - By Stock
|
377
|
102K
|
37
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Completes $3.22m Private Placement
|
|
RaceOncology
|
245 |
49K |
68 |
12/12/25 |
| 12/12/25 |
ASX - By Stock
|
245
|
49K
|
68
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Completes $3.22m Private Placement
|
|
RaceOncology
|
245 |
49K |
31 |
12/12/25 |
| 12/12/25 |
ASX - By Stock
|
245
|
49K
|
31
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Completes $3.22m Private Placement
|
|
RaceOncology
|
245 |
49K |
31 |
12/12/25 |
| 12/12/25 |
ASX - By Stock
|
245
|
49K
|
31
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Completes $3.22m Private Placement
|
|
RaceOncology
|
245 |
49K |
37 |
12/12/25 |
| 12/12/25 |
ASX - By Stock
|
245
|
49K
|
37
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Completes $3.22m Private Placement
|
|
RaceOncology
|
245 |
49K |
134 |
12/12/25 |
| 12/12/25 |
ASX - By Stock
|
245
|
49K
|
134
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Completes $3.22m Private Placement
|
|
RaceOncology
|
245 |
49K |
22 |
11/12/25 |
| 11/12/25 |
ASX - By Stock
|
245
|
49K
|
22
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Completes $3.22m Private Placement
|
|
RaceOncology
|
245 |
49K |
28 |
11/12/25 |
| 11/12/25 |
ASX - By Stock
|
245
|
49K
|
28
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Completes $3.22m Private Placement
|
|
RaceOncology
|
245 |
49K |
110 |
10/12/25 |
| 10/12/25 |
ASX - By Stock
|
245
|
49K
|
110
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Completes $3.22m Private Placement
|
|
RaceOncology
|
245 |
49K |
27 |
10/12/25 |
| 10/12/25 |
ASX - By Stock
|
245
|
49K
|
27
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Completes $3.22m Private Placement
|
|
RaceOncology
|
245 |
49K |
26 |
10/12/25 |
| 10/12/25 |
ASX - By Stock
|
245
|
49K
|
26
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Completes $3.22m Private Placement
|
|
RaceOncology
|
245 |
49K |
33 |
10/12/25 |
| 10/12/25 |
ASX - By Stock
|
245
|
49K
|
33
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Completes $3.22m Private Placement
|
|
RaceOncology
|
245 |
49K |
71 |
10/12/25 |
| 10/12/25 |
ASX - By Stock
|
245
|
49K
|
71
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Completes $3.22m Private Placement
|
|
RaceOncology
|
245 |
49K |
77 |
10/12/25 |
| 10/12/25 |
ASX - By Stock
|
245
|
49K
|
77
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Completes $3.22m Private Placement
|
|
RaceOncology
|
245 |
49K |
73 |
10/12/25 |
| 10/12/25 |
ASX - By Stock
|
245
|
49K
|
73
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Completes $3.22m Private Placement
|
|
RaceOncology
|
245 |
49K |
91 |
10/12/25 |
| 10/12/25 |
ASX - By Stock
|
245
|
49K
|
91
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Discovery of the Anticancer Mechanism of (EE)-bisantrene
|
|
RaceOncology
|
370 |
97K |
22 |
09/12/25 |
| 09/12/25 |
ASX - By Stock
|
370
|
97K
|
22
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Completes $3.22m Private Placement
|
|
RaceOncology
|
245 |
49K |
16 |
09/12/25 |
| 09/12/25 |
ASX - By Stock
|
245
|
49K
|
16
|
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
RaceOncology
|
15K |
5.6M |
69 |
09/12/25 |
| 09/12/25 |
General
|
15K
|
5.6M
|
69
|
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
RaceOncology
|
3.3K |
1.1M |
20 |
09/12/25 |
| 09/12/25 |
ASX - By Stock
|
3.3K
|
1.1M
|
20
|
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
RaceOncology
|
3.3K |
1.1M |
10 |
09/12/25 |
| 09/12/25 |
ASX - By Stock
|
3.3K
|
1.1M
|
10
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Breakthrough Composition of Matter IP Discovery
|
|
RaceOncology
|
377 |
102K |
34 |
09/12/25 |
| 09/12/25 |
ASX - By Stock
|
377
|
102K
|
34
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Completes $3.22m Private Placement
|
|
RaceOncology
|
245 |
49K |
72 |
09/12/25 |
| 09/12/25 |
ASX - By Stock
|
245
|
49K
|
72
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Completes $3.22m Private Placement
|
|
RaceOncology
|
245 |
49K |
129 |
09/12/25 |
| 09/12/25 |
ASX - By Stock
|
245
|
49K
|
129
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Breakthrough Composition of Matter IP Discovery
|
|
RaceOncology
|
377 |
102K |
90 |
08/12/25 |
| 08/12/25 |
ASX - By Stock
|
377
|
102K
|
90
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Discovery of the Anticancer Mechanism of (EE)-bisantrene
|
|
RaceOncology
|
370 |
97K |
31 |
08/12/25 |
| 08/12/25 |
ASX - By Stock
|
370
|
97K
|
31
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Breakthrough Composition of Matter IP Discovery
|
|
RaceOncology
|
377 |
102K |
14 |
08/12/25 |
| 08/12/25 |
ASX - By Stock
|
377
|
102K
|
14
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Discovery of the Anticancer Mechanism of (EE)-bisantrene
|
|
RaceOncology
|
370 |
97K |
21 |
08/12/25 |
| 08/12/25 |
ASX - By Stock
|
370
|
97K
|
21
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Discovery of the Anticancer Mechanism of (EE)-bisantrene
|
|
RaceOncology
|
370 |
97K |
29 |
08/12/25 |
| 08/12/25 |
ASX - By Stock
|
370
|
97K
|
29
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Discovery of the Anticancer Mechanism of (EE)-bisantrene
|
|
RaceOncology
|
370 |
97K |
28 |
08/12/25 |
| 08/12/25 |
ASX - By Stock
|
370
|
97K
|
28
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Discovery of the Anticancer Mechanism of (EE)-bisantrene
|
|
RaceOncology
|
370 |
97K |
30 |
07/12/25 |
| 07/12/25 |
ASX - By Stock
|
370
|
97K
|
30
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Discovery of the Anticancer Mechanism of (EE)-bisantrene
|
|
RaceOncology
|
370 |
97K |
76 |
07/12/25 |
| 07/12/25 |
ASX - By Stock
|
370
|
97K
|
76
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Discovery of the Anticancer Mechanism of (EE)-bisantrene
|
|
RaceOncology
|
370 |
97K |
55 |
07/12/25 |
| 07/12/25 |
ASX - By Stock
|
370
|
97K
|
55
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Discovery of the Anticancer Mechanism of (EE)-bisantrene
|
|
RaceOncology
|
370 |
97K |
117 |
07/12/25 |
| 07/12/25 |
ASX - By Stock
|
370
|
97K
|
117
|
|
|
ASX - By Stock
|
RAC |
Re:
Chat GPT Q&A
|
|
RaceOncology
|
641 |
233K |
39 |
06/12/25 |
| 06/12/25 |
ASX - By Stock
|
641
|
233K
|
39
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Discovery of the Anticancer Mechanism of (EE)-bisantrene
|
|
RaceOncology
|
370 |
97K |
62 |
06/12/25 |
| 06/12/25 |
ASX - By Stock
|
370
|
97K
|
62
|
|
|
ASX - By Stock
|
RAC |
Re:
RAC-010 & RAC-020: Why?
|
|
RaceOncology
|
18 |
5.5K |
28 |
06/12/25 |
| 06/12/25 |
ASX - By Stock
|
18
|
5.5K
|
28
|
|
|
ASX - By Stock
|
RAC |
Re:
Chat GPT Q&A
|
|
RaceOncology
|
641 |
233K |
35 |
06/12/25 |
| 06/12/25 |
ASX - By Stock
|
641
|
233K
|
35
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Discovery of the Anticancer Mechanism of (EE)-bisantrene
|
|
RaceOncology
|
370 |
97K |
27 |
06/12/25 |
| 06/12/25 |
ASX - By Stock
|
370
|
97K
|
27
|
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Discovery of the Anticancer Mechanism of (EE)-bisantrene
|
|
RaceOncology
|
370 |
97K |
38 |
06/12/25 |
| 06/12/25 |
ASX - By Stock
|
370
|
97K
|
38
|
|
|
ASX - By Stock
|
RAC |
Re:
RAC-010 & RAC-020: Why?
|
|
RaceOncology
|
18 |
5.5K |
70 |
06/12/25 |
| 06/12/25 |
ASX - By Stock
|
18
|
5.5K
|
70
|
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
RaceOncology
|
15K |
5.6M |
51 |
05/12/25 |
| 05/12/25 |
General
|
15K
|
5.6M
|
51
|
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
RaceOncology
|
3.0K |
1.0M |
57 |
04/12/25 |
| 04/12/25 |
ASX - By Stock
|
3.0K
|
1.0M
|
57
|
|